Literature DB >> 16102521

Characterisation of the in vitro modulation of splenocyte proliferation by non-4,5-epoxymorphinan opioids.

Mark R Hutchinson1, Andrew A Somogyi.   

Abstract

Opioids, such as morphine, can directly alter immune function via receptors expressed on immunocompetent cells. However, several studies have questioned the classical opioid nature of this change in immune response. Therefore, it is unclear how opioids that are not from the same structural class as morphine (4,5-epoxymorphinan), will modulate the immune system, if they do not behave in a classical opioid manner. Therefore, the aim of this study was to investigate the in vitro modulatory effects of a range of non-4,5-epoxymorphinan opioids on splenocyte proliferation and compare the response characteristics to their central opioid characteristics. The modulation of concanavalin A stimulated mouse splenocyte proliferation by non-4,5-epoxymorphinan opioids resulted in three types of responses: an inhibitory concentration-response curve (e.g. methadone, inhibitory EC(50)=79.4 microM), an inverted bell shaped curve (e.g. fentanyl, inhibitory EC(50)=0.06 microM) and an induction concentration response curve (e.g. nor-binaltorphimine, induction EC(50)=0.16 microM). Non-stereoselectivity, naloxone-insensitivity, naloxone-sensitivity and non-classical opioid rank order of effect were all observed. These data support the non-classical opioid nature of direct opioid modulation of splenocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102521     DOI: 10.1016/j.intimp.2005.05.006

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

1.  Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Annemarie Ledeboer; Julie Wieseler-Frank; Erin D Milligan; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

Review 2.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

3.  Glial TLR4 signaling does not contribute to opioid-induced depression of respiration.

Authors:  Jennifer D Zwicker; Yong Zhang; Jun Ren; Mark R Hutchinson; Kenner C Rice; Linda R Watkins; John J Greer; Gregory D Funk
Journal:  J Appl Physiol (1985)       Date:  2014-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.